日本語 
Recruitment for this clinical study is now complete, and we are no longer accepting new participants. Thank you for your interest
Recruitment for this clinical study is now complete, and we are no longer accepting new participants. Thank you for your interest
Gerossier E, Nayar S, Froidevaux S, et al. Cenerimod, a selective S1P1 receptor modulator, improves organ-specific disease outcomes in animal models of Sjögren’s syndrome. Arthritis Res Ther. 2021;23(1):289.